Literature DB >> 14506967

Rhabdoid differentiation of chromophobe renal cell carcinoma.

Beverley A Shannon1, Ronald J Cohen.   

Abstract

AIMS: Rhabdoid change represents an aggressive form of divergent differentiation previously reported in conventional (clear-cell) and papillary renal cell carcinoma. This study aims to characterise rhabdoid differentiation in a case of chromophobe renal cell carcinoma (ChRCC) and to investigate its origin by genetic analysis.
METHODS: A large tumour mass arising in the right kidney of a 76-year-old male was investigated using routine stains (H&E, Hale's colloidal iron), immunostains (vimentin, cytokeratin) and genetic analysis for loss of heterozygosity (LOH) on chromosomes 1, 2, 3p, 6q, 10q, 13q, 17q, 17p and 21q.
RESULTS: The tumour mass was comprised of the following histological subtypes: (i) typical ChRCC, (ii) eosinophilic variant ChRCC and (iii) rhabdoid variant RCC. Tumour cells of all three different histological subtypes had a positive reaction to Hale's colloidal iron stain, negative immunostaining for vimentin and LOH on chromosomes 2, 10q, 13q and 17p. These results are consistent with a diagnosis of ChRCC and indicate a common genetic origin for all three histological cell types.
CONCLUSIONS: This study confirms that the aggressive rhabdoid variant can arise from ChRCC, as has been previously demonstrated for conventional (clear-cell) and papillary RCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506967     DOI: 10.1080/0031302031000123209

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

1.  Can renal oncocytoma be distinguished from chromophobe renal cell carcinoma by the presence of fibrous capsule?

Authors:  Alma Demirović; Sanja Cesarec; Borislav Spajić; Davor Tomas; Stela Bulimbasić; Milan Milosević; Zlatko Marusić; Bozo Kruslin
Journal:  Virchows Arch       Date:  2009-12-19       Impact factor: 4.064

Review 2.  Chromophobe renal cell carcinoma with rhabdoid differentiation in an adult.

Authors:  Iva Brčić; Borislav Spajić; Božo Krušlin
Journal:  Wien Klin Wochenschr       Date:  2012-06-14       Impact factor: 1.704

3.  Coexistent loss of INI1 and BRG1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI/SNF complex in the pathogenesis of RCC.

Authors:  Qiu Rao; Qiu-Yuan Xia; Qin Shen; Shan-Shan Shi; Pin Tu; Qun-Li Shi; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  Treatment of adult rhabdoid renal cell carcinoma with sorafenib.

Authors:  Anil Kapoor; Robert Tutino; Androniki Kanaroglou; Sebastien J Hotte
Journal:  Can Urol Assoc J       Date:  2008-12       Impact factor: 1.862

5.  Two cases of eosinophilic variant chromophobe renal cell carcinoma, with a rare association of right atrial myxoma in one of them.

Authors:  Sunil Kumar Yeshvanth; Harish S Permi; Kishan Prasad Hosapatna Laxminarayana; Teerthanath Shrinivas; Jayaprakash K Shetty
Journal:  J Lab Physicians       Date:  2011-07

6.  Malignant rhabdoid tumor in the renal allograft of an adult transplant recipient: a unique case of a rare tumor.

Authors:  Jing Xiong; Tiefen Su; Pengcheng Zhu; Qilin Ao; Qiurong Ruan; Guoping Wang
Journal:  Diagn Pathol       Date:  2017-12-19       Impact factor: 2.644

7.  A Composite Renal Tumor with Dual Differentiation, Chromophobe and Collecting Duct Carcinoma.

Authors:  Lauren Pearson; Douglas J Taatjes; Michele von Turkovich; Benjamin J King; Maryam Zenali
Journal:  Case Rep Pathol       Date:  2018-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.